Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, 08908 Barcelona, Spain.
Urology Service, Bellvitge University Hospital, ICS, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Int J Mol Sci. 2023 Mar 13;24(6):5447. doi: 10.3390/ijms24065447.
Reproductive dysfunction and urogenital malignancies represent a serious health concern in men. This is in part as a result of the absence of reliable non-invasive tests of diagnosis/prognosis. Optimizing diagnosis and predicting the patient's prognosis will affect the choice of the most appropriate treatment and therefore increase the chances of success and the result of therapy, that is, it will lead to a more personalized treatment of the patient. This review aims firstly to critically summarize the current knowledge of the reproductive roles played by extracellular vesicle small RNA components, which are typically altered in diseases affecting the male reproductive tract. Secondly, it aims to describe the use of semen extracellular vesicles as a non-invasive source of sncRNA-based biomarkers for urogenital diseases.
生殖功能障碍和泌尿生殖系统恶性肿瘤是男性面临的严重健康问题。这在一定程度上是因为缺乏可靠的非侵入性诊断/预后检测方法。优化诊断并预测患者的预后将影响最合适的治疗选择,从而增加成功的机会和治疗结果,即,它将导致对患者进行更个性化的治疗。本综述的目的首先是批判性地总结目前关于细胞外囊泡小 RNA 成分在影响男性生殖道疾病中的生殖作用的知识,这些成分在疾病中通常会发生改变。其次,它旨在描述使用精液细胞外囊泡作为基于泌尿生殖系统疾病 sncRNA 生物标志物的非侵入性来源。